Skip to content

Clinical trials

Scleroderma, Diffuse trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Country / region: Brazil Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20111
20141
20151
20211
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed3
Recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federal University of São Paulo4
Novartis Pharmaceuticals2
Artiva Biotherapeutics, Inc.1
Bristol-Myers Squibb1
Centro Universitário Augusto Motta1
GlaxoSmithKline1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
University of Campinas, Brazil1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse12
Scleroderma, Systemic5
Arthritis, Rheumatoid3
Connective Tissue Diseases2
Lung Diseases, Interstitial2
Myositis2
Scleroderma, Limited2
Autoimmune Diseases1
Dermatomyositis1
Fibrosis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.